fda statement bpc-157 peptide not approved BPC 157 Banned: Key Facts on the Latest Decision East Texas expert warns of

This finding highlights the potential metabolic importance of intracellular TAG hydrolysis in tissues other than adipose tissue and indicates that desnutrin/ATGL may play a critical role in the liberation of FA in multiple tissues

Strongest human evidence The METAOD006 (OPTIONS) Phase 2b trial randomized 502 adults with obesity (BMI 30-45 kg/m^2) to oral AOD-9604 (0.25, 0.5, or 1 mg/day) or placebo for 24 weeks alongside a supervised diet and exercise program

Sleep disorders : difficulty falling asleep, frequent awakenings at night, restless sleep, early awakenings

Patients considering BPC-157 should be aware that using unlicensed substances carries inherent risks, including unknown side effects, lack of quality control, and potential interactions with prescribed medications